CT:IQ will be formally launched by Minister Hunt and Minister Cash on Wednesday 16 May at the Royal Melbourne Hospital from 10.30am. This event is a collaborative effort and will launch CT:IQ, celebrate the ACTA Clinical Trial of the Year Awards and launch the NHMRC consumer engagement campaign. This will be followed by a CT:IQ lunchtime symposium. Registration is free but numbers are strictly limited: https://acta_awards_2018.eventbrite.com.au

The CI:TQ consortium’s mission is “to develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, leading to more rapid, lower cost and higher quality evaluation of healthcare interventions in Australia”. CT:IQ will drive performance and impact improvements in Australian Clinical Trials; together we will be Thinking Smarter about Clinical Trials.

Rebecca Trowman is the new programme manager at Bellberry leading the initiative. Rebecca has previously worked as a senior policy officer in the Western Australia Department of Health, and as a technical adviser and consultant to the National Institute for Health and Care Excellence (NICE) in the UK. She is also currently working with Health Technology Assessment international (HTAi) on delivering their policy forum series and managing the HTAi interest groups. Her roles have included initiation of a disinvestment work program, workforce and service planning and state-based HTA of health technologies. She has also conducted and supervised the production of HTA appraisals; provided scientific advice to pharmaceutical companies; contributed to the review of the NICE methods guide and represented NICE at international conferences and training events.

Rebecca holds an MSc in Health Services Research and a BSc in mathematics and statistics, and has formal training in systematic reviewing and health economics.

For more information on CT:IQ please contact Rebecca rebeccatrowman@bellberry.com.au

 

Share this article:

Other articles

A blog for the latest news and articles related to the ethical review of human research from Bellberry Limited.

View all articles
Apr 30, 2026

Impact Report 2025

We’re proud to share Bellberry’s 2025 Impact Report - our first report bringing together key insights, data and achievements from the past…

Read More
Feb 17, 2026

2026 Podcast Season: More About NAMs

When a potential new medicine is tested on humans for the first time it is a milestone. It is thoroughly tested for…

Read More
Dec 23, 2025

Bellberry Newsletter – Summer 2025

Welcome to our newsletter for summer 2025. The Bell contains a roundup of the activities Bellberry has been involved with in the…

Read More
Nov 12, 2025

2025/26 Bellberry-Viertel Fellow Announced

Last month at the Australian Academy of Health and Medical Sciences Gala Dinner in Canberra our new Bellberry-Viertel Fellow was announced! Congratulations…

Read More
Sep 30, 2025

National Statement Updates 2025

The National Statement on Ethical Conduct in Human Research is the principal reference for research involving humans in Australia and is the…

Read More
Sep 30, 2025

Operations Update 28

In the September issue of our Operations Update please find articles on: New Bellberry office address New eProtocol registrations contact email Bellberry…

Read More
Sep 30, 2025

Bellberry User Satisfaction Survey

As Australia’s largest provider of Human Research Ethics Committee services, Bellberry places great value on understanding the experience our users have of…

Read More
Sep 30, 2025

International Research Administrators Day

Today, September 25, we celebrate International Research Administrators Day! This globally recognised day honours the contribution of Research Administrators in supporting and…

Read More
Jun 12, 2025

NAMs workshop summary report released

We are pleased to release the summary report from the Bellberry & ASCEPT New Approach Methodologies (NAMs) Introductory Workshop, held in Melbourne,…

Read More
May 21, 2025

Clinical Trial Activity Report (CTAR) 2024

Report highlights international confidence in Australian clinical trials Global investment in Australian clinical trials is strong, with two thirds of Australian clinical…

Read More
May 21, 2025

Podcast Episode 12: From Lab to Life

Worldwide there is growing focus on using NAMs (Non-Animal Models also known as Novel Approach Methods) in the development of therapeutics. In…

Read More
Mar 11, 2025

Participant Engagement at Scientific Meetings

Bellberry is delighted to share details of our grant program to support participant engagement at scientific meetings. Conference organisers can apply to…

Read More
Feb 14, 2025

Podcast Episode 11: From Lab To Life

In 2004 Bellberry was founded as a paradigm breaker. We are an institutionally independent not-for-profit company that offers Human Research Ethics Committee…

Read More
Nov 29, 2024

Bellberry wins National Award for Health!

We are delighted to share that Bellberry won the National Telstra Best of Business award in the Championing Health category in Melbourne…

Read More
Nov 26, 2024

Telstra Best of Business Award – National Finalist!

Bellberry CEO Kylie Sproston and Communications Manager Alison Rogers, are on their way to Melbourne today in preparation for their final pitch…

Read More